Article Text
Statistics from Altmetric.com
My son, Alfie, was born 6 years into my role as an academic consultant neurologist with an interest in epilepsy. On his second day he was floppier than expected, and so was referred for a brain scan that revealed multiple malformations, the cause of which was never determined. He had his first seizure at 3 months of age, evolving into a clear developmental epileptic encephalopathy within weeks. By age 18 months he had specialist seating, PEG feeds, a tracheostomy, home oxygen and was ventilator-assisted. He was multisensory impaired, and had very little trunk or head control ever, though on a good day could kick and hit out at noisy toys with some purpose. He smiled, laughed, loved swimming, tasters and cuddles, and knew those most familiar to him (figures 1 and 2). Alfie far outlived initial expectations, but died after a short illness in April 2016, leaving a legacy through organ donation, through the many lives he touched, and through all that I learnt from him (supplementary data).
Supplemental material
If you have a chronic, life-threatening or life-limiting condition, particularly if it is unpredictable as with epilepsy, knowing there is an accessible …
Other content recommended for you
- Phase II randomised placebo-controlled trial of sodium selenate as a disease-modifying treatment in chronic drug-resistant temporal lobe epilepsy: the SeLECT study protocol
- Surgical outcomes in patients with epileptogenic tumours and cavernomas in Sweden: good seizure control but late referrals
- Treatment of difficult epilepsy
- Recent developments in the surgical management of paediatric epilepsy
- Treatment changes in a cohort of people with apparently drug-resistant epilepsy: an extended follow-up
- Drug treatment of epilepsy in adults
- The benefit of active drug trials is dependent on aetiology in refractory focal epilepsy
- Alternative approaches to conventional antiepileptic drugs in the management of paediatric epilepsy
- Outcome of epilepsy surgery in focal cortical dysplasia
- NICE guideline review: Epilepsies in children, young people and adults NG217